SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-24-000078
Filing Date
2024-08-16
Accepted
2024-08-16 16:07:41
Documents
3
Period of Report
2024-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1723838854.html 4  
1 FORM 4 wk-form4_1723838854.xml 4 6937
2 EX-24 kmanchesterpoa.htm EX-24 11651
3 kmanchesterpoa001.jpg GRAPHIC 227242
  Complete submission text file 0001447028-24-000078.txt   333290
Mailing Address C/O ROIVANT SCIENCES LTD. 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FL LONDON X0 SW1Y 4L
Business Address
MANCHESTER KEITH S (Reporting) CIK: 0001244828 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 241216756

Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)